During the past decade, Quentin Allen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Quentin Allen" are "Cataract" (1 trials) and "Cataract Surgery" (1 trials). Many other conditions were trialed in "Quentin Allen" in a lesser frequency.

Most popular intervention types in "Quentin Allen" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alcon PanOptix or PanOptix Toric IOL" (1 trials) and "Alcon Vivity or Vivity Toric IOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quentin Allen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Quentin Allen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Quentin Allen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Quentin Allen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".